Development Of Immediate And Sustained-release Formulations Of The Glp-1 Receptor Agonist, Exenatide, For The Treatment Of Patients With Type 2 Diabetes
Boeklezers.nl is a network for social reading. We help readers discover new books and authors, and bring readers in contact with each other and with writers. Read more ».
Reviews of Development Of Immediate And Sustained-release Formulations Of The Glp-1 Receptor Agonist, Exenatide, For The Treatment Of Patients With Type 2 Diabetes by M.S. Fineman